Stock Analysis
- Hong Kong
- /
- Medical Equipment
- /
- SEHK:2252
Shanghai MicroPort MedBot (Group) Full Year 2023 Earnings: EPS Misses Expectations
Shanghai MicroPort MedBot (Group) (HKG:2252) Full Year 2023 Results
Key Financial Results
- Revenue: CN¥104.6m (up 384% from FY 2022).
- Net loss: CN¥1.01b (loss narrowed by 11% from FY 2022).
- CN¥1.06 loss per share (improved from CN¥1.19 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Shanghai MicroPort MedBot (Group) EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.7%.
Looking ahead, revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Medical Equipment industry in Hong Kong.
Performance of the Hong Kong Medical Equipment industry.
The company's shares are up 22% from a week ago.
Risk Analysis
Before you take the next step you should know about the 3 warning signs for Shanghai MicroPort MedBot (Group) (1 shouldn't be ignored!) that we have uncovered.
Valuation is complex, but we're helping make it simple.
Find out whether Shanghai MicroPort MedBot (Group) is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:2252
Shanghai MicroPort MedBot (Group)
Shanghai MicroPort MedBot (Group) Co., Ltd.
Mediocre balance sheet with limited growth.